Nanomedicines and Vaccines
NANO-VAC
Hospital Universitari de Tarragona Joan XXIII
Tarragona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Tarragona Joan XXIII (6)
2024
-
Serum Amyloid A as a Potential Biomarker for Disease Activity in Chronic Spontaneous Urticaria
Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 1, pp. 195-200
2022
-
Angioedema severity and impact on quality of life: Chronic histaminergic angioedema versus chronic spontaneous urticaria
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 11, pp. 3039-3043.e3
2021
-
A Comparative Study of Sex Distribution, Autoimmunity, Blood, and Inflammatory Parameters in Chronic Spontaneous Urticaria with Angioedema and Chronic Histaminergic Angioedema
Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 6, pp. 2284-2292
2019
-
Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial
Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 5, pp. 1599-1609.e1
2004
-
Epidemiology of urticaria in Spain
Journal of Investigational Allergology and Clinical Immunology, Vol. 14, Núm. 3, pp. 214-220
-
Prevalencia de alergia en la población adulta Española
Alergologia e Inmunologia Clinica, Vol. 19, Núm. 2, pp. 68-74